Molecular Oncology
Volume 3, Issue 2 , Pages 157-164 , April 2009

Large-scale genomic analysis of ovarian carcinomas

  • Kylie L. Gorringe

      Affiliations

    • VBCRC Cancer Genetics Laboratory, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia
    • Department of Pathology, University of Melbourne, Melbourne, Victoria, Australia
    • ,
  • Ian G. Campbell

      Affiliations

    • VBCRC Cancer Genetics Laboratory, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia
    • Department of Pathology, University of Melbourne, Melbourne, Victoria, Australia
    • Corresponding Author InformationCorrespondence to: Ian Campbell, VBCRC Cancer Research Laboratory, Peter MacCallum Cancer Centre, Locked Bag 1, A'Beckett St., Melbourne, VIC 8006, Australia. Tel.: +61 3 96561803; fax: +61 3 96561411.

Received 21 October 2008 ,Revised 8 December 2008 ,Accepted 11 December 2008.

References 

  1. Albert TJ, Molla MN, Muzny DM, Nazareth L, Wheeler D, Song X, et al Direct selection of human genomic loci by microarray hybridization. Nature Methods. 2007;4:903–905
  2. Bainbridge MN, Warren RL, Hirst M, Romanuik T, Zeng T, Go A, et al Analysis of the prostate cancer cell line LNCaP transcriptome using a sequencing-by-synthesis approach. BMC Genomics. 2006;7:246
  3. Baker VV, Borst MP, Dixon D, Hatch KD, Shingleton HM, Miller D. c-myc amplification in ovarian cancer. Gynecologic Oncology. 1990;38:340–342
  4. Baudis M, Cleary ML. Progenetix.net: an online repository for molecular cytogenetic aberration data. Bioinformatics (Oxford, England). 2001;17:1228–1229
  5. Bayani J, Brenton JD, Macgregor PF, Beheshti B, Albert M, Nallainathan D, et al Parallel analysis of sporadic primary ovarian carcinomas by spectral karyotyping, comparative genomic hybridization, and expression microarrays. Cancer Research. 2002;62:3466–3476
  6. Bernardini M, Lee CH, Beheshti B, Prasad M, Albert M, Marrano P, et al High-resolution mapping of genomic imbalance and identification of gene expression profiles associated with differential chemotherapy response in serous epithelial ovarian cancer. Neoplasia (New York, NY). 2005;7:603–613
  7. Bignell GR, Santarius T, Pole JC, Butler AP, Perry J, Pleasance E, et al Architectures of somatic genomic rearrangement in human cancer amplicons at sequence-level resolution. Genome Research. 2007;17:1296–1303
  8. Binladen J, Gilbert MT, Bollback JP, Panitz F, Bendixen C, Nielsen R, et al. The use of coded PCR primers enables high-throughput sequencing of multiple homolog amplification products by 454 parallel sequencing. PLoS ONE. 2007;2:e197
  9. Birrer MJ, Johnson ME, Hao K, Wong KK, Park DC, Bell A, et al. Whole genome oligonucleotide-based array comparative genomic hybridization analysis identified fibroblast growth factor 1 as a prognostic marker for advanced-stage serous ovarian adenocarcinomas. Journal of Clinical Oncology. 2007;25:2281–2287
  10. Brown LA, Irving J, Parker R, Kim H, Press JZ, Longacre TA, et al Amplification of EMSY, a novel oncogene on 11q13, in high grade ovarian surface epithelial carcinomas. Gynecologic Oncology. 2006;100:264–270
  11. Campbell IG, Russell SE, Choong DY, Montgomery KG, Ciavarella ML, Hooi CS, et al. Mutation of the PIK3CA gene in ovarian and breast cancer. Cancer Research. 2004;64:7678–7681
  12. Campbell PJ, Stephens PJ, Pleasance ED, O'Meara S, Li H, Santarius T, et al Identification of somatically acquired rearrangements in cancer using genome-wide massively parallel paired-end sequencing. Nature Genetics. 2008;40:722–729
  13. Cavenee WK, Dryja TP, Phillips RA, Benedict WF, Godbout R, Gallie BL, et al. Expression of recessive alleles by chromosomal mechanisms in retinoblastoma. Nature. 1983;305:779–784
  14. Craig DW, Pearson JV, Szelinger S, Sekar A, Redman M, Corneveaux JJ, et al Identification of genetic variants using bar-coded multiplexed sequencing. Nature Methods. 2008;5:887–893
  15. Dahl F, Stenberg J, Fredriksson S, Welch K, Zhang M, Nilsson M, et al. Multigene amplification and massively parallel sequencing for cancer mutation discovery. Proceedings of the National Academy of Sciences of the United States of America. 2007;104:9387–9392
  16. Enomoto T, Weghorst CM, Inoue M, Tanizawa O, Rice JM. K-ras activation occurs frequently in mucinous adenocarcinomas and rarely in other common epithelial tumors of the human ovary. The American Journal of Pathology. 1991;139:777–785
  17. Feltmate CM, Lee KR, Johnson M, Schorge JO, Wong KK, Hao K, et al. Whole-genome allelotyping identified distinct loss-of-heterozygosity patterns in mucinous ovarian and appendiceal carcinomas. Clinical Cancer Research. 2005;11:7651–7657
  18. Forbes S, Clements J, Dawson E, Bamford S, Webb T, Dogan A, et al Cosmic 2005. British Journal of Cancer. 2006;94:318–322
  19. Futreal PA, Coin L, Marshall M, Down T, Hubbard T, Wooster R, et al. A census of human cancer genes. Nature Reviews. 2004;4:177–183
  20. Gilks CB, Ionescu DN, Kalloger SE, Kobel M, Irving J, Clarke B, et al. Tumor cell type can be reproducibly diagnosed and is of independent prognostic significance in patients with maximally debulked ovarian carcinoma. Human Pathology. 2008;39:1239–1251
  21. Gorringe KL, Campbell IG. High-resolution copy number arrays in cancer and the problem of normal genome copy number variation. Genes, Chromosomes and Cancer. 2008;
  22. Gorringe KL, Jacobs S, Thompson ER, Sridhar A, Qiu W, Choong DY, et al. High-resolution single nucleotide polymorphism array analysis of epithelial ovarian cancer reveals numerous microdeletions and amplifications. Clinical Cancer Research. 2007;13:4731–4739
  23. Greshock J, Feng B, Nogueira C, Ivanova E, Perna I, Nathanson K, et al. A comparison of DNA copy number profiling platforms. Cancer Research. 2007;67:10173–10180
  24. Gunnarsson R, Staaf J, Jansson M, Ottesen AM, Goransson H, Liljedahl U, et al Screening for copy-number alterations and loss of heterozygosity in chronic lymphocytic leukemia – a comparative study of four differently designed, high resolution microarray platforms. Genes, Chromosomes and Cancer. 2008;47:697–711
  25. Haas CJ, Diebold J, Hirschmann A, Rohrbach H, Lohrs U. In serous ovarian neoplasms the frequency of Ki-ras mutations correlates with their malignant potential. Virchows Archives. 1999;434:117–120
  26. Hauptmann S, Denkert C, Koch I, Petersen S, Schluns K, Reles A, et al. Genetic alterations in epithelial ovarian tumors analyzed by comparative genomic hybridization. Human Pathology. 2002;33:632–641
  27. Hodges E, Xuan Z, Balija V, Kramer M, Molla MN, Smith SW, et al Genome-wide in situ exon capture for selective resequencing. Nature Genetics. 2007;39:1522–1527
  28. Hu J, Khanna V, Jones MW, Surti U. Comparative study of primary and recurrent ovarian serous carcinomas: comparative genomic hybridization analysis with a potential application for prognosis. Gynecologic Oncology. 2003;89:369–375
  29. Jacobs S, Thompson ER, Nannya Y, Yamamoto G, Pillai R, Ogawa S, et al. Genome-wide, high-resolution detection of copy number, loss of heterozygosity, and genotypes from formalin-fixed, paraffin-embedded tumor tissue using microarrays. Cancer Research. 2007;67:2544–2551
  30. Janne PA, Li C, Zhao X, Girard L, Chen TH, Minna J, et al. High-resolution single-nucleotide polymorphism array and clustering analysis of loss of heterozygosity in human lung cancer cell lines. Oncogene. 2004;23:2716–2726
  31. Kallioniemi A, Kallioniemi OP, Sudar D, Rutovitz D, Gray JW, Waldman F, et al. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science (New York, NY). 1992;258:818–821
  32. Kiechle M, Jacobsen A, Schwarz-Boeger U, Hedderich J, Pfisterer J, Arnold N. Comparative genomic hybridization detects genetic imbalances in primary ovarian carcinomas as correlated with grade of differentiation. Cancer. 2001;91:534–540
  33. Kim SW, Kim JW, Kim YT, Kim JH, Kim S, Yoon BS, et al. Analysis of chromosomal changes in serous ovarian carcinoma using high-resolution array comparative genomic hybridization: potential predictive markers of chemoresistant disease. Genes, Chromosomes and Cancer. 2007;46:1–9
  34. Knudson AG. Mutation and cancer: statistical study of retinoblastoma. Proceedings of the National Academy of Sciences of the United States of America. 1971;68:820–823
  35. Knutsen T, Gobu V, Knaus R, Padilla-Nash H, Augustus M, Strausberg RL, et al. The interactive online SKY/M-FISH and CGH database and the Entrez cancer chromosomes search database: linkage of chromosomal aberrations with the genome sequence. Genes, Chromosomes and Cancer. 2005;44:52–64
  36. Lambros MB, Fiegler H, Jones A, Gorman P, Roylance RR, Carter NP, et al. Analysis of ovarian cancer cell lines using array-based comparative genomic hybridization. The Journal of Pathology. 2005;205:29–40
  37. Ley TJ, Mardis ER, Ding L, Fulton B, McLellan MD, Chen K, et al DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome. Nature. 2008;456:66–72
  38. Liu Y, Ganesan TS. Tumour suppressor genes in sporadic epithelial ovarian cancer. Reproduction (Cambridge, England). 2002;123:341–353
  39. Mitelman F, Johansson B, Mertens F. Mitelman Database of Chromosome Aberrations in Cancer. 2008;http://cgap.nci.nih.gov/Chromosomes/Mitelman
  40. Mitelman F, Mertens F, Johansson B. A breakpoint map of recurrent chromosomal rearrangements in human neoplasia. Nature Genetics. 1997;15(Spec No.):417–474
  41. Obata K, Morland SJ, Watson RH, Hitchcock A, Chenevix-Trench G, Thomas EJ, et al. Frequent PTEN/MMAC mutations in endometrioid but not serous or mucinous epithelial ovarian tumors. Cancer Research. 1998;58:2095–2097
  42. Osterberg L, Levan K, Partheen K, Helou K, Horvath G. Cytogenetic analysis of carboplatin resistance in early-stage epithelial ovarian carcinoma. Cancer Genetics and Cytogenetics. 2005;163:144–150
  43. Partheen K, Levan K, Osterberg L, Helou K, Horvath G. Analysis of cytogenetic alterations in stage III serous ovarian adenocarcinoma reveals a heterogeneous group regarding survival, surgical outcome, and substage. Genes, Chromosomes and Cancer. 2004;40:342–348
  44. Press JZ, De Luca A, Boyd N, Young S, Troussard A, Ridge Y, et al Ovarian carcinomas with genetic and epigenetic BRCA1 loss have distinct molecular abnormalities. BMC Cancer. 2008;8:17
  45. Ramus SJ, Pharoah PD, Harrington P, Pye C, Werness B, Bobrow L, et al BRCA1/2 mutation status influences somatic genetic progression in inherited and sporadic epithelial ovarian cancer cases. Cancer Research. 2003;63:417–423
  46. Rao PH, Harris CP, Yan Lu X, Li XN, Mok SC, Lau CC. Multicolor spectral karyotyping of serous ovarian adenocarcinoma. Genes, Chromosomes and Cancer. 2002;33:123–132
  47. Redon R, Ishikawa S, Fitch KR, Feuk L, Perry GH, Andrews TD, et al Global variation in copy number in the human genome. Nature. 2006;444:444–454
  48. Slamon DJ, Godolphin W, Jones LA, Holt JA, Wong SG, Keith DE, et al Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science (New York, NY). 1989;244:707–712
  49. Sonoda G, Palazzo J, du Manoir S, Godwin AK, Feder M, Yakushiji M, et al. Comparative genomic hybridization detects frequent overrepresentation of chromosomal material from 3q26, 8q24, and 20q13 in human ovarian carcinomas. Genes, Chromosomes and Cancer. 1997;20:320–328
  50. Sugarbaker DJ, Richards WG, Gordon GJ, Dong L, De Rienzo A, Maulik G, et al Transcriptome sequencing of malignant pleural mesothelioma tumors. Proceedings of the National Academy of Sciences of the United States of America. 2008;105:3521–3526
  51. Taetle R, Aickin M, Yang JM, Panda L, Emerson J, Roe D, et al Chromosome abnormalities in ovarian adenocarcinoma: I. Nonrandom chromosome abnormalities from 244 cases. Genes, Chromosomes and Cancer. 1999;25:290–300
  52. Thomas RK, Nickerson E, Simons JF, Janne PA, Tengs T, Yuza Y, et al Sensitive mutation detection in heterogeneous cancer specimens by massively parallel picoliter reactor sequencing. Nature Medicine. 2006;12:852–855
  53. Tomlinson IP, Lambros MB, Roylance RR. Loss of heterozygosity analysis: practically and conceptually flawed?. Genes, Chromosomes and Cancer. 2002;34:349–353
  54. Tothill RW, Tinker AV, George J, Brown R, Fox SB, Lade S, et al Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome. Clinical Cancer Research. 2008;14:5198–5208
  55. Walsh CS, Ogawa S, Scoles DR, Miller CW, Kawamata N, Narod SA, et al. Genome-wide loss of heterozygosity and uniparental disomy in BRCA1/2-associated ovarian carcinomas. Clinical Cancer Research. 2008;14:7645–7651
  56. Yamada K, Takagi N, Sandberg AA. Chromosomes and causation of human cancer and leukemia. II. Karyotypes of human solid tumors. Cancer. 1966;19:1879–1890

PII: S1574-7891(08)00153-1

doi: 10.1016/j.molonc.2008.12.005

Molecular Oncology
Volume 3, Issue 2 , Pages 157-164 , April 2009

Article Tools

* Image Usage & Resolution